Ertugliflozin is a sodium glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Ertugliflozin is indicated for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise as monotherapy.<\/p>\n
What is STEGLATRO? \u2022 STEGLATRO is a prescription medicine used in adults with type 2 diabetes to improve blood sugar (glucose) control along with diet and exercise. \u2022 STEGLATRO is not for people with type 1 diabetes. It may increase the risk of diabetic ketoacidosis in these people. \u2022 It is not known if STEGLATRO is safe and effective in children under 18 years of age.\u00a0 Active ingredient: ertugliflozin. Inactive ingredients: microcrystalline cellulose, lactose monohydrate, sodium starch glycolate, and magnesium stearate. The tablet film coating contains the following inactive ingredients: hypromellose, lactose monohydrate, macrogol, triacetin, titanium dioxide, and iron oxide red.<\/p>\n
STEGLATRO (ertugliflozin tablets) for oral use Initial U.S. Approval: 2013
\nTo access ertugliflozin tablets sold under the brand name can be made available on request to patient if the drug has not been approved or is not available in your country. For information or advice, call IPN’s Pharmaceutical Expert. Our expert will be happy to take your query and guide with an effective solution. Be free and call today for full support at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj)<\/p>\n","protected":false},"excerpt":{"rendered":"
STEGLATRO is a sodium glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.<\/p>\n
Approval Date: \u00a02017 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cErtugliflozin Tablets\u201d based on the information you provide.<\/strong><\/p>\n
\nProprietary Name: \u00a0STEGLATRO (ertugliflozin) tablets
\nActive Ingredient(s): \u00a0ertugliflozin tablets
\nDosage Form: \u00a0Tablets: 5 mg and 15 mg
\nMedicine Approved By: Food and Drug Administration (FDA)
\nManufacturer: Merck Sharp & Dohme Corp.
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n